Clinical-genetic correlations in familial Alzheimer's disease caused by presenilin 1 mutations

Journal of Alzheimer's Disease

Volumn 19, Issue 3, 2010, Pages 873-884

  Gómez Tortosa, Estrella ^a   Barquero, Sagrario ^b   Barón, Manuel ^c   Gil Neciga, Eulogio ^d   Castellanos, Fernando ^e   Zurdo, Martín ^e   Manzano, Sagrario ^b   Muoz, David G ^f   Jiménez Huete, Adolfo ^g   Rábano, Alberto ^c   Sainz, M José ^a   Guerrero, Rosa ^a   Gobernado, Isabel ^h   Pérez Pérez, Julián ⁱ   Jiménez Escrig, Adriano ^h  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL VIRGEN DEL PUERTO   (Spain)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g HOSPITAL RUBER INTERNACIONAL   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ Secugen SL   (Spain)

Author keywords

Early onset; Familial Alzheimer's disease; Mutations; Presenilin 1

Indexed keywords

AMINO ACID; PRESENILIN 1;

ADULT; AGED; AGGRESSIVENESS; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DEMENTIA; EPILEPTIC DISCHARGE; EXON; FAMILIAL DISEASE; FEMALE; GENETIC CORRELATION; HUMAN; LANGUAGE DISABILITY; MALE; MYOCLONUS; NEUROLOGIC DISEASE; ONSET AGE; PARKINSONISM; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SEIZURE; SPASTIC PARAPLEGIA;

EID: 77149121108     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1292     Document Type: Article

References (41)

1. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
2. Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E, Rogaev EI, Frommelt P, Sadovnick AD, Meschino W, Rockwood K, Boss MA, Mayeux R, St George-Hyslop P (2001) Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 57, 621-625.
3. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, Brice A, FrebourgT(1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65, 664-670.
4. Lléo A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Peña-Casanova J, Rojo A, Oliva R (2002) Frequency of mutations in the presenilin and amyloid precursor protein genes in earlyonset Alzheimer disease in Spain. Arch Neurol 59, 1759-1763.
5. Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D (2005) Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet 42, 793-795.
6. Kamimura K, Tanahashi H, Yamanaka H, Takahashi K, Asada T, Tabira T (1998) Familial Alzheimer's disease genes in Japan. J Neurol Sci 160, 76-81.
7. Mehta ND, Refolo LM, Eckman C, Sanders S,Yager D, Perez- Tur J, Younkin S, Duff K, Hardy J, HuttonM(1998) Increased Aβ42(43) from cell lines expressing presenilin 1 mutations. Ann Neurol 43, 256-258.
8. Ishii K, II K, Hasegawa T, Shoji S, Doi A, Mori H (1997) Increased Aβ42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. Neurosci Lett 228, 17-20.
9. Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, Binetti G, Alberici A, Hock C, Nitsch RM, Gal A (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet 66, 110-117.
10. Zekanowski C, Styczynska M, Peplonska B, Gabryelewicz T, Religa D, Ilkowski J, Kijanowska-Haladyna B, Kotapka-Minc S, Mikkelsen S, Pfeffer A, Barczak A, Luczywek E, Wasiak B, Chodakowska-Zebrowska M, Gustaw K, Laczkowski J, Sobow T, Kuznicki J, Barcikowska M (2003) Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland. Exp Neurol 184, 991-996.
11. Anheim M, Hannequin D, Boulay C, Martin C, Campion D, Tranchant C (2007) Ataxic variant of Alzheimer's disease caused by Pro117Ala PS1 mutation. J Neurol Neurosurg Psychiatry 78, 1414-1415.
12. Kauwe JS, Wang J, Chakraverty S, Goate AM, Henao- Martinez AF (2008) Novel presenilin 1 variant (P117A) causing Alzheimer's disease in the fourth decade of life. Neurosci Lett 438, 257-259.
13. Wisniewski T, Dowjat WK, Buxbaum JD, Khorkova O, Efthimiopoulos S, Kulczycki J, Lojkowska W,Wegiel J, Wisniewski HM, Frangione B (1998) A novel Polish presenilin- 1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. NeuroReport 9, 217-221.
14. Alberici A, Bonato C, Borroni B, Cotelli M, Mattioli F, Binetti G, Gennarelli M, Luca MD, Simonati A, Perani D, Rossini P, Padovani A (2007) Dementia, delusions and seizures: storage disease or genetic AD. Eur J Neurol 14, 1057-1059.
15. Dowjat WK,Kuchna I,Wisniewski T,Wegiel J (2004) A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations. J Alzheimers Dis 6, 31-43.
16. Reznik-Wolf H, Treves TA, Davidson M, Aharon-Peretz J, St George Hyslop PH, Chapman J, Korczyn AD, Goldman B, Friedman E (1996) A novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis. Hum Genet 98, 700-702.
17. Poorkaj P, Sharma V, Anderson L, Nemens E, Alonso ME, Orr H, White J, Heston L, Bird TD, Schellenberg GD (1998) Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene. Hum Mutation 11, 216-221.
18. Hutton M, Busfield F, Wragg M, Crook R, Perez-Tur J, Clark RF, Prihar G, Talbot C, Phillips H, Wright K, Baker M, Lendon C, Duff K, Martinez A et al. (1996) Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuro report 7, 801-805. (Pubitemid 26146875)
19. Tanahashi H, Kawakatsu S, Kaneko M, Yamanaka H, Takahashi K, Tabira T (1996) Sequence analysis of presenilin 1 gene mutation in Japanese Alzheimer's disease patients. Neurosci Lett 218, 139-141.
20. Kamino K, Sato S, Sakaki Y,Yoshiiwa A, Nishiwaki Y. Takeda M, Tanabe H, Nishimura T, II K, St George-Hyslop PH, Miki T, Ogihara T (1996) Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families. Neurosci Lett 208, 195-198.
21. Poduslo SE, Herring K, NealM(1996)Apresenilin 1 mutation in an early onset Alzheimer's family: no association with presenilin 2. Neuro report 7, 2018-2020.
22. Axelman K, Basun H, Lannfelt L (1998)Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch Neurol 55, 698-702.
23. Zekanowski C, Golan MP, Krzysko KA, Lipczynska- Lojkowska W, Filipek S, Kowalska A, Rossa G, Peplonska B, Styczynska M, Maruszak A, Religa D, Wender M, Kulczycki J, Barcikowska M, Kuznicki J (2006) Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment. Exp Neurol 200, 82-88.
24. Coleman P, Kurlan R, Crook R, Werner J, Hardy J (2004) A new presenilin Alzheimer's disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5. Neurosci Lett 364, 139-140.
25. Jiménez Caballero PE, de Diego Boguna C, Martin Correa E, Servía Candela M, Marsal Alonso C (2008) A novel presenilin 1 mutation (V261L) associated with presenile Alzheimer's disease and spastic paraparesis. Eur J Neurol 15, 991-994.
26. Farlow MR, Murrell J, Unverzagt FW, Phillips M, Takao M, Ghetti B, Hulette C (2001) Familial Alzheimer's disease with spastic paraparesis associated with a mutation at codon 261 of the presenilin 1 gene. In Alzheimer's disease: advances in etiology, pathogenesis and therapeutics, Iqbal K, Sisodia SS, Winblad B, eds. Chichester, John Wiley, pp 53-60.
27. Jimenez-Escrig A, Rabano A, Guerrero C, Simon J, Barquero MS, Guell I, Ginestal RC, Montero T, Orensanz L (2004) New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism. Eur J Neurol 11, 663-669.
28. Guerreiro RJ, Baquero M, Blesa R, Boada M, Bŕas JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, Ǵomez-Isla T, Herńandez I, Lléo A, Machado A, Mart́inez-Lage P, Masdeu J, Molina-Porcel L, Molinuevo JL, Pastor P, Pérez-Tur J, Relvas R, Oliveira CR, Ribeiro MH, Rogaeva E, Sa A, Samaranch L, Śanchez-Valle R, Santana I, T̀arraga L, Valdivieso F, Singleton A, Hardy J, Clariḿon J (2008) Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging, in press.
29. Aldudo J, Bullido MJ, Arbizu T, Oliva R, Valdivieso F (1998) Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease. Neurosci Lett 240, 174-176.
30. Dermaut B, Kumar-Singh S, De Jonghe C, Cruts M, Löfgren A, Lübke U, Cras P, Dom R, De Deyn PP, Martin JJ, Van Broeckhoven C (2001) Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 124, 2383-2392.
31. Larner AJ, Doran M (2006) Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 253, 139-158.
32. Lippa CF, Swearer JM, Kane KJ, Nochlin D, Bird TD, Ghetti B, Nee LE, St. George-Hyslop P, Pollen DA, Drachman DA (2000) Familial Alzheimer's disease site of mutation influences clinical phenotype. Ann Neurol 48, 376-379.
33. Seidner GA, Ye Y, Faraday MM, Alvord WG, Fortini ME (2006) Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila. Curr Biol 16, 1026-10
34. Duering M, Grimm MO, Grimm HS, Schröder J, Hartmann T (2005) Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42. Neurobiol Aging 26, 785-788.
35. Piccini A, Zanusso G, Borgui R, Noviello C, Monaco S, Russo R, Damonte G, Armirotti A, Gelati M, Giordano R, Zambenedetti P, Russo C, Ghetti B, Tabaton M (2007) Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype. Arch Neurol 64, 738-745.
36. Alzheimer's Disease Collaborative Group (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD. Nat Genet 11, 219-222.
37. Hardy J, Crook R (2001) Presenilin mutations line up along transmembrane β-helices. Neurosci Lett 306, 203-205.
38. Finckh U,Kuschel C, Anagnostouli M, Patsouris E, PantesGV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A (2005) Novel mutation and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 6, 85-89.
39. Larner AJ, Ray PS, Doran M (2007) The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease. J Neurol Sci 252, 173-176.
40. Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, Gnjec A, Ghika J, Suard F, Mehta PD, McLean CA, Masters CL, Brooks WS, Martins RN (2003) Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Azheimer's disease. Neurobiol Aging 24, 655-662.
41. Berezovska O, Lleo A, Herl LD, FroschMP, Stern EA, Bacskai BJ, Hyman BT (2005) Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 25, 3009-3017.